Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Recruiting · NCT06335771 · Registry updated 2026-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity | Body Weight, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-08-06 | NCT06335771 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Missouri School of Medicine | Columbia | United States | 9 |